0001179110-19-004095.txt : 20190320
0001179110-19-004095.hdr.sgml : 20190320
20190320160225
ACCESSION NUMBER: 0001179110-19-004095
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190318
FILED AS OF DATE: 20190320
DATE AS OF CHANGE: 20190320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Myer Vickesh
CENTRAL INDEX KEY: 0001742806
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37687
FILM NUMBER: 19694679
MAIL ADDRESS:
STREET 1: C/O EDITAS MEDICINE, INC.
STREET 2: 11 HURLEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Editas Medicine, Inc.
CENTRAL INDEX KEY: 0001650664
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 464097528
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11 HURLEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: 617-401-9000
MAIL ADDRESS:
STREET 1: 11 HURLEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
4
1
edgar.xml
FORM 4 -
X0306
4
2019-03-18
0
0001650664
Editas Medicine, Inc.
EDIT
0001742806
Myer Vickesh
C/O EDITAS MEDICINE, INC.
11 HURLEY ST.
CAMBRIDGE
MA
02141
0
1
0
0
Chief Technology Officer
Common Stock
2019-03-18
4
M
0
3000
0.65
A
3000
D
Common Stock
2019-03-18
4
S
0
3000
24.50
D
0
D
Stock Option (right to buy)
0.65
2019-03-18
4
M
0
3000
0
D
2025-04-29
Common Stock
3000
73307
D
The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017.
This option was granted on April 30, 2015 and is scheduled to vest over four years, with 25% of the shares having vested on April 21, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through April 21, 2019.
/s/ Vickesh Myer
2019-03-20